Matinas BioPharma Holdings, Inc.
MTNB
$0.87
-$0.01-1.14%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 80.36% | -97.26% | 25.25% | 1.80% | -9.60% |
| Total Depreciation and Amortization | -48.18% | 1.23% | 1.24% | 0.42% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -200.00% | -- |
| Total Other Non-Cash Items | -99.54% | 374.17% | -0.41% | -2.31% | -22.87% |
| Change in Net Operating Assets | -681.40% | 119.68% | -130.82% | 218.36% | -50.69% |
| Cash from Operations | 42.82% | -0.29% | -12.69% | 46.16% | -25.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -94.82% | 428.32% | -246.90% | -32.43% |
| Cash from Investing | -- | -94.82% | 428.32% | -246.90% | -32.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 50.00% | -100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | 16,918.52% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 164,800.00% | 98.51% | -100.73% | 17,237.74% | 5,400.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.04% | -149.53% | 93.29% | 184.63% | -129.38% |